BioVoice News October 2016 Issue 6 Volume 1 | Page 19

bio personality

SUDHASHU VRATI TAKES CHARGE AT REGIONAL CENTRE FOR BIOTECHNOLOGY
Dr Sudhanshu Vrati has been appointed as the Executive Director
of the Regional Centre for Biotechnology , a part of the Faridabad Biocluster of the Department of Biotechnology . Dr Vrati was earlier serving as the Executive Director of the Translational Health Research and Technology institute . He has also been a senior scientist at National Institute of Immunology ( NII ), New Delhi , and also actively involved with THSTI since 2005 .
With rich biotechnology background and deep research experience , his present research interest lies in the area of RNA virus replication and vaccine development . His group at the VIDRC within THSTI focuses on key aspects of the JEV life-cycle like receptor binding and entry mechanisms , molecular mechanisms of virus replication , assembly and egress . Besides , he has been also involved in the clinical development of an oral rotavirus vaccine .
Dr Vrati did his Masters in Microbiology from G . B . Pant University of Agriculture and Technology in Pantnagar , DIIT in Biochemical Engineering from Indian Institute of Technology Delhi and PhD in Biochemistry from the Australian National University in Canberra . He did his postdoctoral research at CSIRO Molecular Sciences in Sydney .
BIOCON APPOINTS SURESH SUBRAMANIAN AS HEAD OF BRANDED FORMULATIONS ( INDIA ) BUSINESS
Mr Suresh Subramanian has been appointed as Senior Vice President and Head of the Biocon ' s Branded Formulations ( India ) business . Suresh has over 30 years of experience in the pharmaceuticals market , having worked in India and Thailand for MNCs such as GlaxoSmithKline , Novartis , AstraZeneca and Pfizer . Over the years , he has played multiple leadership roles in Business Development , Marketing , Sales and Strategy . He has a rich experience of multiple product launches , business optimization , cost control , talent development and performance management . He has also played a critical role in mapping the pharma opportunity in India as part of the Steering Committee for McKinsey ‘ s India Pharma 2020 report .
Ms Kiran Mazumdar-Shaw , CMD , Biocon , said : " We are extremely delighted to have Suresh Subramanian lead our Branded Formulations business in India . Suresh has deep expertise in diverse therapy areas including Oncology , Cardiology and Critical Care and has a proven track record of delivering robust business growth . We are sure , under his leadership , our Branded Formulations business will evolve further and become a strong value builder for Biocon ."
GSK CONSUMER HEALTHCARE APPOINTS RAJ KHEMANI AS THE IT LEAD
GSK Consumer Healthcare has announced the appointment of Mr Raj Khemani as the IT Lead , ISC on
September 18 , 2016 . Raj will be a member of the India Leadership Team and will be based in Gurgaon . Raj joins GSK from Clariant India where he was the Vice President , IT , managing information security strategy , SAP processes and leveraging them for business .
Raj ’ s earlier role was at Bristol-Myers Squibb , where he was the IT Head & Information Security Lead for Asia Pacific & Japan . Prior to this , he was with Pfizer where he was managing the business technology processes . He also had stints with Microsoft and Ranbaxy in the capacity of Technical Lead and Project Lead respectively . Raj has a degree in Business Data Processing and Economics from Delhi University .
On his appointment , Mr Raj Khemani said , “ I am delighted to be a part of GSK Consumer Healthcare family and look forward to collaborate across functions . To be associated with a consumer brand of such lineage and repute is a great privilege . I hope to add value and contribute in raising the benchmark for business excellence .”
Mr Manoj Kumar , Managing Director , GSK Consumer Healthcare , said “ I am excited to have Raj join our leadership team . He brings with him over 16 years of experience and has an exceptional track record of business successes in each of his previous roles . His deep understanding of information technology coupled with extensive learning across sectors will further augment our business capabilities . I wish him success in his new role .”
BIOVOICENEWS . COM 19